Exhibit 107
Calculation of Filing Fee Table
FORM S-1
(Form Type)
AYTU BIOPHARMA, INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security |
Security Class Title |
Fee |
Amount |
Proposed |
Maximum Price (1) |
Fee Rate |
Amount of |
|
Fees to Be Paid |
Equity |
Common Stock, par value $0.0001 per share (2) |
457(o) |
$13,800,000 |
0.00015310 |
$2,112.78 |
||
Other |
Prefunded Warrants to purchase shares of Common Stock (3) |
Other |
— |
(3) |
||||
Equity |
Common Stock underlying the Prefunded Warrants (2)(3) |
457(o) |
— |
|||||
Total Offering Amounts |
$13,800,000 |
0.00015310 |
$2,112.78 |
|||||
Total Fees Previously Paid |
$1,837.20 |
|||||||
Total Fee Offsets |
— |
|||||||
Net Fee Due |
$275.58 |
(1) |
Estimated solely for the purpose of calculating the amount of the registration fee in pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”) |
(2) |
Pursuant to Rule 416 under the Securities Act, this registration statement shall also cover any additional shares of the registrant’s securities that become issuable by reason of any share splits, share dividends, recapitalizations, or similar transactions. |
(3) |
The proposed maximum aggregate offering price of the shares of Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any prefunded warrants issued in the offering, and the proposed maximum aggregate offering price of the prefunded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any shares of Common Stock issued in the offering. |
(4) |
Please note that the Registrant previously paid a fee of $1,837.20 for a transaction with the Total Offering Amount of $12,00,000 pursuant to a registration statement on Form S-1 filed on June 2, 2025. The revised Total Offering Amount is $13,800,000. |